These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 6151892

  • 1. Alpha- and beta-blockade in angina pectoris.
    Taylor SH.
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [Abstract] [Full Text] [Related]

  • 2. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R, Bassenge E.
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [Abstract] [Full Text] [Related]

  • 3. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE, Hill JA, Feldman RL.
    Am J Cardiol; 1987 May 01; 59(12):1084-8. PubMed ID: 2883869
    [Abstract] [Full Text] [Related]

  • 4. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH, Strom JA, Kirschner M, Poland M, Klein N, Halprin S, LeJemtel TH, Kram M, Sonnenblick EH.
    Am J Cardiol; 1981 Nov 01; 48(5):917-28. PubMed ID: 6118060
    [No Abstract] [Full Text] [Related]

  • 5. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
    Frishman WH.
    Cardiovasc Drugs Ther; 1988 Sep 01; 2(3):343-53. PubMed ID: 2908732
    [Abstract] [Full Text] [Related]

  • 6. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN.
    Drugs; 1984 Sep 01; 28 Suppl 2():51-68. PubMed ID: 6151891
    [Abstract] [Full Text] [Related]

  • 7. Combined receptor intervention and myocardial infarction.
    Chamberlain DA, Vincent R.
    Drugs; 1984 Sep 01; 28 Suppl 2():88-108. PubMed ID: 6151893
    [Abstract] [Full Text] [Related]

  • 8. Beta blockade and the effects of stress on the normal and ischaemic heart.
    Prichard BN.
    Aviat Space Environ Med; 1981 Nov 01; 52(11 Pt 2):S9-18. PubMed ID: 6118124
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview.
    Oh VM.
    Ann Acad Med Singap; 1980 Oct 01; 9(4):498-507. PubMed ID: 6113811
    [Abstract] [Full Text] [Related]

  • 10. Antianginal actions of beta-adrenoceptor antagonists.
    O'Rourke ST.
    Am J Pharm Educ; 2007 Oct 15; 71(5):95. PubMed ID: 17998992
    [Abstract] [Full Text] [Related]

  • 11. Labetalol in the treatment of angina pectoris.
    Kanto JH.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar 15; 25(3):166-74. PubMed ID: 2881899
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF, White DA.
    S Afr Med J; 1983 Jan 15; 63(3):67-71. PubMed ID: 6849167
    [Abstract] [Full Text] [Related]

  • 13. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM, Spencer M.
    Br J Clin Pharmacol; 1979 Jan 15; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [Abstract] [Full Text] [Related]

  • 14. Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
    Lubbe WF, White DA.
    Clin Sci Mol Med Suppl; 1978 Dec 15; 4():283s-286s. PubMed ID: 32006
    [Abstract] [Full Text] [Related]

  • 15. The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectoris.
    Fitzgerald JD.
    Acta Med Scand Suppl; 1985 Dec 15; 694():120-41. PubMed ID: 2860771
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ, McNeil JJ, Drummer OH.
    Drugs; 1984 Dec 15; 28 Suppl 2():16-34. PubMed ID: 6151889
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF.
    Postgrad Med J; 1976 Dec 15; 52 Suppl 4():43-5. PubMed ID: 9630
    [Abstract] [Full Text] [Related]

  • 18. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G.
    Acta Med Scand; 1986 Dec 15; 219(1):17-22. PubMed ID: 2869648
    [Abstract] [Full Text] [Related]

  • 19. The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
    Nelson GI, Silke B, Ahuja RC, Hussain M, Forsyth D, Taylor SH.
    Eur Heart J; 1984 Jan 15; 5(1):67-79. PubMed ID: 6705807
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists.
    Prichard BN.
    Z Kardiol; 1990 Jan 15; 79 Suppl 3():99-103. PubMed ID: 1983055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.